Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasma DNA Methylation‐Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1

Molecular Carcinogenesis(2024)10.1002/mc.23825Source: DataRank Database

Plasma DNA Methylation‐Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1 is a research paper published in Molecular Carcinogenesis (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.93)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Manishkumar S. Patel ORCID,Angela D. Bhalla ORCID,Christine B. Peterson ORCID,Sharon M. Landers ORCID,S. Carson Callahan ORCID

Live enrichment

PubMed:39600120 PMC:PMC11636586 OpenAlex:https://openalex.org/W4404773641

NCI NIH HHS

Grant: R01 CA285980

NCI NIH HHS

Grant: P30 CA016672

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

This work was partially supported by The Texas Neurofibromatosis Foundation, the Sally M. Kingsbury Sarcoma Research Foundation, A Shelter for Cancer Families, The Ferrin Randall Zeitlin Foundation for Sarcoma Research, Mojo's Miracle, and the Jay Vernon Jackson Liposarcoma Fund. C.B.P. was partially supported by the National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30CA016672.

FWCI

1.93

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mc.23825

journalhttps://doi.org/10.1002/mc.23825

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39600120

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11636586

repositoryhttps://digitalcommons.library.tmc.edu/uthgsbs_docs/3260

Fields of Study

Neurofibromatosis and Schwannoma CasesSarcoma Diagnosis and TreatmentChromatin Remodeling and Cancer0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AdultAgedFemaleHumansMaleMiddle AgedNeurofibromatosis 1Biomarkers, TumorNeurofibrosarcomaCpG IslandsDNA MethylationCell Line, Tumor

Keywords

NeurofibromatosisDNA methylationBiologyCpG siteCancer researchNeurofibromaMethylationBiomarkerMalignant peripheral nerve sheath tumorOncologyPathologyGeneticsMedicineGeneGene expressionPlasmaNeurofibromatosis Type 1MpnstMaleAdultNeurofibromatosis 1Middle AgedNeurofibrosarcomaCell Line, TumorBiomarkers, TumorHumansCpG IslandsFemaleResearch ArticleAged

Sustainable Development Goals

SDG 0: Reduced inequalities